GlassScriptPhysician profile
Ronya Lashelle Green
NPI 1174834824
$4,106.28
in general payments reported to CMS, 2019-2025
24 companies · $3,473 in 2025
The $3,473 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.55 · 2021: $390 · 2022: $107 · 2023: $96.78 · 2025: $3,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,715 · Travel and Lodging: $553 · Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,715.00 |
| Travel and Lodging | $553.28 |
| Food and Beverage | $301.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $3,472.63 | 2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $68.61 | 2021 | |
| Novo Nordisk INC | $66.79 | 2021-2023 | |
| Dexcom, INC. | $48.36 | 2021 | |
| Daiichi Sankyo INC. | $40.92 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.47 | 2022 | |
| Amgen INC. | $35.94 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.53 | 2021 | |
| Amarin Pharma, INC. | $32.86 | 2021 | |
| Esperion Therapeutics, INC. | $23.30 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.73 | 2022 | |
| Alkermes, INC. | $22.45 | 2023 | Aristada, Lybalvi |
| Coopersurgical, INC. | $20.51 | 2022 | |
| Merck Sharp & Dohme LLC | $20.00 | 2019 | |
| Pfizer INC. | $18.84 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.91 | 2021 | |
| Dynavax Technologies Corporation | $17.59 | 2023 | Heplisav-B |
| Lilly USA, LLC | $17.03 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.23 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.09 | 2021 | |
| Exact Sciences Corporation | $13.86 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $12.97 | 2021 | |
| Almatica Pharma LLC | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronya Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.